Pharma

By Jonah Comstock June 1, 2016
Roche Diagnostics has launched a Bluetooth-connected device for testing blood coagulation in Europe. The CoaguChek INRange system has received a CE Mark, and an older version of the device without the Bluetooth connectivity is already available in the US and in Europe. The Bluetooth connectivity allows patients undergoing Vitamin K antagonist therapy to self-monitor their blood coagulation with a...
By Jonah Comstock May 24, 2016
Propeller Health has announced yet another collaboration with a pharmaceutical company. The Madison, Wisconsin-based company will parter with the Chippenham, UK-based Vectura Group, an independent pharma company focused exclusively on inhaler drugs for respiratory conditions. “Digital health has the potential to make respiratory therapies more personal, powerful and convenient for every patient...
By Jonah Comstock May 5, 2016
Through its enterprise partnership with Apple, IBM will create a clinical calculation app for cataract surgeons for eye care company Bausch + Lomb, a subsidiary of Valeant Pharmaceuticals, the companies announced this morning. “If you think about all the mobile solutions throughout the industry and what we do as consumers, we needed to carry that forward and make it easier for our surgeons, and...
By Jonah Comstock April 27, 2016
The FDA declined to approve what would have been the first mass market drug to incorporate Proteus Digital Health's ingestible sensor. The drug, a collaboration between Proteus and Otsuka Pharmaceuticals, combines the Proteus system with the antipsychotic pharmaceutical Abilify. “While we are disappointed in the FDA’s decision not to approve this digital medicine at this time, both Otsuka and...
By Jonah Comstock April 21, 2016
HealthPrize, a Norwalk, Connecticut-based medication adherence platform company, released data this week demonstrating a 99 percent reduction in “gap days” — days between running out of a medication and filling that medication — in patients using its program.  The data comes from a cohort of 1,085 patients taking a branded cholesterol-lowering medication (HealthPrize wasn’t able to disclose which...
By Aditi Pai April 19, 2016
About a year after pharmaceutical company Roche announced an investment in diabetes app company mySugr, the companies announced an integration partnership. MySugr offers a handful of apps, but its flagship is called Diabetes Logbook, which is designed for people with type 1 or type 2 diabetes and includes logging, graphing, analysis, and Apple Health integration. If users sign up for a month-to-...
By MHN Staff April 14, 2016
As we do every quarter, MobiHealthNews has rounded up our Q1 2016 coverage into a handful of longform stories. This section is on pharma. Skip ahead using these links to read Q1 digital health news roundups about providers, payers, M&A and funding. Novartis Novartis announced a partnership with Qualcomm Life, a subsidiary of Qualcomm, to develop a connected version of its inhaler, Breezhaler...
By MHN Staff April 8, 2016
More and more, pharma companies are making real bets in digital health, and reorganizing their businesses to put some power behind those efforts. The space is, in some ways, quieter than it was this time last year, but there’s reason to believe that quiet is a calm before a storm of activity, driven more by pharma’s tendency to keep early-stage projects close to the chest than by a lack of...
By Aditi Pai April 7, 2016
Pfizer has partnered with IBM to develop a system that clinicians can use to treat patients who have Parkinson’s disease. The system will make use of sensors, mobile devices, and machine learning to provide clinicians and researchers with symptom information, which they will then use to better understand patient disease progression and medication response. It will also help inform treatment...
By Brian Dolan April 4, 2016
Proteus Digital Health announced interim study results from a randomized control study of its Proteus Discover timed with the American College of Cardiology event, ACC.16, in Chicago this week. The study included 96 patients with uncontrolled hypertension and type 2 diabetes and showed that a majority of the patients using the digital offering achieved the blood pressure target at week four. The...